We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Phase II/III Clinical Trial for COVID-19 Vaccine Begins at NYU Langone Health

News   Jul 28, 2020 | Original story from NYU Langone Health

 
Phase II/III Clinical Trial for COVID-19 Vaccine Begins at NYU Langone Health

Credit: Aom Woraluck/rawpixel

 
 
Advertisement
 

RELATED ARTICLES

Could Psoriatic Arthritis Be Activated by the Same Receptor in Different Patients?

News

A new study has revealed psoriatic arthritis may be activated by the same trigger in different patients. Researchers identified high levels of a specific receptor in immune cells, giving promising evidence of a single cause for the disease.

READ MORE

Drug Shown To Modulate the Inflammatory Response in Severe COVID-19

News

Scientists have identified a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

READ MORE

Stroke Patients With COVID-19 Show Increased Inflammation and Stroke Severity

News

Stroke patients who also have COVID-19 showed increased systemic inflammation, a more serious stroke severity and a much higher rate of death, compared to stroke patients who did not have COVID-19, according to a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE